Laidlaw Wealth Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-897
Closed -$219K 432
2021
Q4
$219K Buy
+897
New +$196K 0.04% 371
2021
Q3
Sell
-1,769
Closed -$330K 287
2021
Q2
$330K Sell
1,769
-130
-7% -$22.6K 0.09% 190
2021
Q1
$299K Buy
1,899
+210
+12% +$33.3K 0.1% 168
2020
Q4
$280K Sell
1,689
-59
-3% -$9.6K 0.06% 274
2020
Q3
$289K Buy
1,748
+89
+5% +$13.7K 0.13% 159
2020
Q2
$227K Sell
1,659
-51
-3% -$6.66K 0.12% 159
2020
Q1
$201K Buy
1,710
+131
+8% +$17.2K 0.13% 141
2019
Q4
$209K Buy
+1,579
New +$196K 0.13% 157

Other funds holding ZTS

Laidlaw Wealth Management's ZTS Position: Q1 2022 in Review

Laidlaw Wealth Management sold out of Zoetis (ZTS) in Q1 2022, closing a stake of 897 shares — an estimated $219K sold.

Laidlaw Wealth Management first reported a position in ZTS in Q4 2019 and held it in 8 quarters. The position peaked at $330K in Q2 2021. 1,637 funds tracked by Wall St. Rank hold ZTS as of Q1 2022.

  • Laidlaw Wealth Management reported no remaining Zoetis position as of Q1 2022 after selling out during the quarter.
  • Laidlaw Wealth Management sold 897 Zoetis shares in Q1 2022, an estimated $219K.
  • Laidlaw Wealth Management first reported a position in Zoetis in Q4 2019 and held it in 8 quarters.
  • Laidlaw Wealth Management's Zoetis position peaked at $330K in Q2 2021.
  • 1,637 funds tracked by Wall St. Rank held Zoetis as of Q1 2022.

Based on Laidlaw Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.